| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/15/2011 | WO2011112002A2 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011012609A3 Anti - tgf - beta receptor type ii single domain antibodies |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224282 iRNA Agents Targeting VEGF |
| 09/15/2011 | US20110224275 Inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224268 Compositions and methods of using R(+) pramipexole |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224244 Adamantyl Benzamide Derivatives |
| 09/15/2011 | US20110224220 Substituted tricyclic derivatives |
| 09/15/2011 | US20110224200 Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde 0-(piperidin-1-yl-propyl)-oxime derivative as active ingredient |
| 09/15/2011 | US20110224192 3-Arylamino Pyridine Derivatives |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224171 Inhibitors of fatty acid amide hydrolase |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224155 Modulation of chemosensory receptors and ligands associated therewith |
| 09/15/2011 | US20110224154 Peptide derivative and composition for promoting tear secretion comprising the same |
| 09/15/2011 | US20110224145 Neuromodulators and Methods of Use |
| 09/15/2011 | US20110223269 Agent for treating eye diseases |
| 09/15/2011 | US20110223246 Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source |
| 09/15/2011 | US20110223177 Treatment of fibrotic eye disorders |
| 09/15/2011 | US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors |
| 09/15/2011 | US20110223170 Klk-13 antibody inhibitor for treating dry eye |
| 09/15/2011 | US20110223169 Il-17 antibody inhibitor for treating dry eye |
| 09/15/2011 | US20110223166 Methods for Preventing Pressure-Induced Apoptotic Neural-Cell Death |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223140 Method for differentiation into retinal cells from stem cells |
| 09/15/2011 | US20110223126 Ophthalmic composition |
| 09/15/2011 | CA2792520A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | CA2792407A1 Beta-adrenergic receptor agonists and uses thereof |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2790407A1 Ophthalmic formulations |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364710A1 Therapeutic use of D-allose |
| 09/14/2011 | EP2364708A2 Pharmaceutical composition comprising a C1C-2 channel opener |
| 09/14/2011 | EP2364707A2 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 09/14/2011 | EP2301580A9 Container holding anti-VEGF antibodies |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102186873A New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 09/14/2011 | CN102186479A Aminopyrimidine inhibitors of histamine receptors for the treatment of disease |
| 09/14/2011 | CN102178956A Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 09/14/2011 | CN102178936A Methods for preparing collagen oleostock and moistening eyedrops |
| 09/14/2011 | CN102178928A Application of cobra venom neurotoxin in drugs for treating ametropia |
| 09/14/2011 | CN102178925A Novel eyesight protective agent lutein ophthalmic preparation |
| 09/14/2011 | CN102178923A Preparation method of traditional Chinese medicament for treating swelling tympanitis in external auditory meatus |
| 09/14/2011 | CN102178863A Method for preparing traditional Chinese medicine for treating liver-meridian and heat stagnation type tympanitis |
| 09/14/2011 | CN102178815A Traditional Chinese medicine for treating ischemic optic neuropathy |
| 09/14/2011 | CN102178796A Application of active ingredients of juncus effuses in preparation of medicaments for resisting tumors or inhibiting angiogenesis, health-care food or cosmetics |
| 09/14/2011 | CN102178784A Combination therapy used for treating visual disturbances and damages and relieving asthenopia |
| 09/14/2011 | CN102178723A Optimization and pilot scale of extraction process route of effective part resisting tumor angiogenesis in cortex albiziae |
| 09/14/2011 | CN102178696A Method for preparing amino acid chelated full-nutritional pearls |
| 09/14/2011 | CN102178692A Compositions of hyaluronic acid and methods of use |
| 09/14/2011 | CN102178649A Rapamycin liposome eye drops and preparation method thereof |
| 09/14/2011 | CN102178647A Pranlukast injection preparation |
| 09/14/2011 | CN102178644A Timolol maleate (TM) eye gel and preparation method thereof |
| 09/14/2011 | CN101912490B Traditional Chinese medical preparation for treating otitis media |
| 09/14/2011 | CN101869631B Toxicant elimination medicament for eyes |
| 09/14/2011 | CN101785756B Celtezole sodium suspension preparation |
| 09/14/2011 | CN101721591B Health-care product for eye |
| 09/14/2011 | CN101606976B Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology |
| 09/14/2011 | CN101233110B Substance with oxidation resistance, agedness protection and anti-ischemia active and preparing method thereof |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017116 Using growth factor specific immunoglobulin as therapeutic in treating eye tissue injury |
| 09/13/2011 | CA2522318C Drug for preventing or treating angiogenic eye diseases |
| 09/13/2011 | CA2469075C Pyrrolidine derivatives as prostaglandin modulators |
| 09/13/2011 | CA2467763C Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 09/13/2011 | CA2356836C Novel streptococcus antigens |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2271690C Methods for regulating angiogenesis |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011108681A1 Anti-allergic agent, and method for producing same |
| 09/09/2011 | WO2011107981A1 A3ar agonists for the treatment of uveitis |
| 09/09/2011 | WO2011107334A1 Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| 09/09/2011 | WO2011107259A1 Nutraceutical chocolate or compound chocolate product |
| 09/09/2011 | WO2011049958A3 Modulation of gel temperature of poloxamer-containing formulations |
| 09/09/2011 | WO2011049954A3 Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders |
| 09/09/2011 | CA2790869A1 A3ar agonists for the treatment of uveitis |
| 09/09/2011 | CA2790097A1 Nutraceutical chocolate or compound chocolate product |
| 09/08/2011 | US20110218238 Compounds, compositions, formulations and their uses thereof |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218219 Substituted sulphonamido phenoxybenzamides |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218206 Individual and combination of mdivi-1 and nutlin-3 for topical or intravitreal ophthalmic use |
| 09/08/2011 | US20110218205 Piperazine derivatives |
| 09/08/2011 | US20110218192 Inhibitors Of Beta-Secretase |
| 09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 09/08/2011 | US20110217329 Vaccine |
| 09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |
| 09/08/2011 | US20110217287 Therapeutic composition comprising a botulinum neurotoxin |
| 09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
| 09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
| 09/08/2011 | US20110217262 Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability |